Clinical Trials Directory

Trials / Completed

CompletedNCT04733937

Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort

Protocol Title: Comparative Effects of A2 Platinum® Stage 1 Infant Formula Versus Conventional Stage 1 Infant Formula Containing A1 and A2 Β-casein Versus Breast Feeding on Infant Digestion and Comfort: a Single-blind Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
a2 Milk Company Ltd. · Industry
Sex
All
Age
0 Days – 76 Days
Healthy volunteers
Accepted

Summary

This trial is a single-blind, randomized, controlled, parallel-designed trial to compare the effects of a2 Platinum® stage 1 infant formula versus conventional, A1 and A2 β-casein-containing stage 1 infant formula versus breastfeeding on crying, tolerance, gut health, and immune function.

Detailed description

The protocol was updated from V8.2 to V9.1 and was approved by the Ethical Committee of Shanghai First Maternity and Infant Hospital, the main site. The major changes are: from "blind to participants" to "non-blind to participants"; from "Single-Centre" to "Multi-Centre"; number of subjects from "270" to "180"; trial period from "3 weeks" to "4 weeks"; and number of visits from "6" to "4".

Conditions

Interventions

TypeNameDescription
OTHERa2 Platinum® stage 1 infant formulaUpon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.
OTHERConventional, A1 and A2 β-casein containing stage 1 infant formulaUpon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.

Timeline

Start date
2021-07-07
Primary completion
2022-04-16
Completion
2022-04-16
First posted
2021-02-02
Last updated
2024-10-18

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04733937. Inclusion in this directory is not an endorsement.